Grants

  • Cycle 1: Alzheimer’s Drug Discovery Foundation

    LOI Due Dates: Cycle 1: April 10, 2020 Cycle 2: July 10, 2020 Cycle 3: October 9, 2020 Drug Development Program The goal of this RFP is to develop therapeutics for Alzheimer’s disease and related dementias. This RFP focuses on building preclini...

    July 10
    |Recurring Event (See all)

    One event on July 10, 2020 at 12:00 am

    One event on October 9, 2020 at 12:00 am

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

    Sponsor: National Institutes of Health (multiple Institutes) LOI Due Date: July 12, 2020, January 10, 2021 Application Due Date: August 11, 2020, February 9, 2021 Award: Application budgets are not limited but must reflect the actual needs of the pr...

    July 12
    |Recurring Event (See all)

    One event on January 10, 2021 at 12:00 am

  • CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U44 Clinical Trial Optional)  

    Sponsor: National Institutes of Health (NIH) Due Date: July 20, 2020 Award: This Funding Opportunity Announcement (FOA) supports the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene t...

    July 20

  • CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U01 Clinical Trial Optional)

    Sponsor: National Institutes of Health (NIH) Due Date: July 20, 2020 Award: This Funding Opportunity Announcement (FOA) supports the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene th...

    July 20

  • BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3)

    Sponsor: National Institutes of Health LOI Due Dates: May 23, 2020, September 21, 2020 Application Deadlines: June 22, 2020, October 21, 2020 Award: The NIH anticipates providing $10M per year to fund an estimated 5 to 7 awards. Application budgets...

    September 21
    |Recurring Event (See all)

    One event on September 21, 2020 at 12:00 am

  • AES Research and Training Workshops

    Sponsor: American Epilepsy Society Due Dates:  Cycle 1: May 4, 2020 Cycle 2: September 23, 202o Award: AES welcomes applications for funding to support scientific conferences and workshops focused on epilepsy research and training. Applications for ...

    September 23
    |Recurring Event (See all)

    One event on September 23, 2020 at 12:00 am

  • AES Seed Grant Program 

    Sponsor: American Epilepsy Society Due Dates:  Cycle 1: May 4, 2020 Cycle 2: September 28, 2020 Award: The AES Seed Grant Program provides support to established investigators to pursue new and innovative directions in epilepsy research, bring new r...

    September 28
    |Recurring Event (See all)

    One event on September 28, 2020 at 12:00 am

  • Broad PCORI Funding Announcements

    Sponsor: Patient-Centered Outcomes Research Institute LOI Due Date: September 29, 2020 at 5pm ET Application Due Date: January 12, 2021 at 5pm ET Award: The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patie...

    September 29

  • NIH R01 Cycles

    Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional): The purpose of this funding opportunity announcement (FOA) is to stimulate clinical resea...

    October 5
    |Recurring Event (See all)

    One event on June 5, 2020 at 12:00 am

    One event on October 5, 2020 at 12:00 am

  • Cycle 1: Alzheimer’s Drug Discovery Foundation

    LOI Due Dates: Cycle 1: April 10, 2020 Cycle 2: July 10, 2020 Cycle 3: October 9, 2020 Drug Development Program The goal of this RFP is to develop therapeutics for Alzheimer’s disease and related dementias. This RFP focuses on building preclini...

    October 9
    |Recurring Event (See all)

    One event on July 10, 2020 at 12:00 am

    One event on October 9, 2020 at 12:00 am

  • NIH R21, R03

    DUE DATES:  Cycle 3: October 16, 2019 by 5 PM of local organization time Cycle 1: February 16, 2020 by 5 PM of local organization time Cycle 2: June 16, 2020 by 5 PM of local organization time Biobehavioral and Technological Interventions to Attenua...

    October 16
    |Recurring Event (See all)

    One event on February 16, 2020 at 12:00 am

    One event on June 16, 2020 at 12:00 am

    One event on October 16, 2020 at 12:00 am

  • Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

    Sponsor: National Institutes of Health Due Date: November 6, 2020 Award: This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, proposing the development of innovative, collaborative research p...

    November 6

  • Community Action Grants

    Sponsor: American Association of University Women Due Date: December 1, 2020 Award: Community Action Grants provide funding to individuals, AAUW branches and AAUW state organizations as well as community-based nonprofits for innovative programs or no...

    December 1

  • ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

    Sponsor: International Rett Syndrome Foundation (IRSF) Due Date: Applications accepted on a rolling basis Award: Up to $600,000 over two years. Grant awards must be comprised of very specific programs that are focused on pre-clinical drug discovery a...

    December 31

  • Rolling Basis: Alzheimer’s Drug Discovery Foundation

    PROPOSALS ACCEPTED ON A ROLLING BASIS ADDF/NIH Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities. Conference Funding Supports scientific conferences that are re...

    December 31
View All Events